Llwytho...
Nivolumab in combination with ipilimumab for the treatment of melanoma
Melanoma patients develop resistance to most therapies, including chemo- and targeted-therapy drugs. Single-agent therapies are ineffective due to the heterogeneous nature of tumors comprising several subpopulations. Treatment of melanoma with immune-based therapies such as anti-cytotoxic T-lymphocy...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Expert Rev Anticancer Ther |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4669949/ https://ncbi.nlm.nih.gov/pubmed/26402246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2015.1093418 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|